Inspired by Patients. Driven by Purpose. Proven by Outcomes.
Curant Rare is the next generation of rare disease specialty pharmacy, where compassionate support, and real-world insights converge to deliver extraordinary outcomes.
Driving better outcomes, together
For over 25 years, we’ve improved the lives of patients by challenging the status quo. We transform every rare disease journey through compassionate, high-touch care, ensuring access to critical therapies, removing barriers, and leveraging real-time insights and real-world evidence to guide personalized treatment. By partnering closely with patients, providers, and manufacturers, we deliver meaningful support at every step, making complex care simple, connected, and impactful. As the bridge between patients, caregivers, and the broader rare disease community, we make sure every individual feels supported, empowered, and connected to the communities that understand their journey best.
Where Rare Meets Remarkable
%
Aggregated Adherence Rate Measured as Total PDC Across All Member Populations
%
Highly Satisfied Providers Bridging the gap between member, plan & provider
Net Promoter Score (NPS) Validating Our Best-in-Class Member Satisfaction
Institutional Review Board (IRB) Clinical Studies Validating Our Outcomes
Years of independence and and proven success in patient-centered care.
Redefining Rare Care
Every patient has a story. Every treatment, intervention, and program we deliver touches a life, helping patients feel supported, empowered, and cared for.
Real-Time Insights Across the Patient & Program Journey
Our proprietary platforms uncover clinical risks, track referrals, and enable informed action.
Clinical Intelligence
- Meaningful clinical insights
- Therapy appropriateness
- Adverse events
- Drug interactions
- Emerging patient needs
Referral Visibility
- End-to-end transparency into the referral journey
- Real-time status updates
- Stakeholder alignment
Actionable Data
- Turn complex clinical and operational data into actionable intelligence
- Drive smarter decisions
- Identify and resolve timely interventions
News & Resources
Recent Updates
Curant Rare and IntraBio Bring Real-World Evidence to Niemann-Pick Disease Type C Care
Curant Rare and IntraBio Bring Real-World Evidence to Niemann-Pick Disease Type C CareReal-world data is essential to understanding how therapies perform beyond clinical trials, particularly in rare diseases like Niemann-Pick disease type C (NPC). As healthcare...
Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products
Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug ProductsAtlanta, GA – Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide...
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare has been selected by Corcept Therapeutics as a specialty pharmacy to provide personalized care, coordinated access to...
Every .
Projects
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics
Curant Rare Announces Exclusive Pharmacy Partnership for IWILFIN™